{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T19:16:30Z","timestamp":1774379790326,"version":"3.50.1"},"reference-count":48,"publisher":"Elsevier BV","issue":"13","license":[{"start":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T00:00:00Z","timestamp":1107216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2005,2]]},"DOI":"10.1016\/j.vaccine.2004.06.056","type":"journal-article","created":{"date-parts":[[2004,11,8]],"date-time":"2004-11-08T18:47:18Z","timestamp":1099939638000},"page":"1615-1623","source":"Crossref","is-referenced-by-count":41,"title":["Intranasal immunisation with defective adenovirus serotype 5 expressing the Venezuelan equine encephalitis virus E2 glycoprotein protects against airborne challenge with virulent virus"],"prefix":"10.1016","volume":"23","author":[{"given":"R.J.","family":"Phillpotts","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"O\u2019Brien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.E.","family":"Appleton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Carr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2004.06.056_bib1","series-title":"Field's virology","first-page":"P917","author":"Griffin","year":"2001"},{"key":"10.1016\/j.vaccine.2004.06.056_bib2","first-page":"79","article-title":"Venezuelan equine encephalitis","volume":"18","author":"Johnson","year":"1974","journal-title":"Adv Vet Sci Comp Med"},{"key":"10.1016\/j.vaccine.2004.06.056_bib3","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1001\/jama.1943.02840520004002","article-title":"Human infection with Venezuelan equine encephalomyelitis virus","volume":"123","author":"Lennette","year":"1943","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.vaccine.2004.06.056_bib4","doi-asserted-by":"crossref","unstructured":"The Subcommittee on Arbovirus Laboratory Safety of the American Committee on Arthropod-borne viruses. Laboratory safety for arborviruses and certain other viruses of vertebrates. Am J Trop Med Hyg 1980;29:1359\u201381.","DOI":"10.4269\/ajtmh.1980.29.1359"},{"key":"10.1016\/j.vaccine.2004.06.056_bib5","first-page":"209","article-title":"Attenuation of Venezuelan equine encephalomyelitis virus by in vitro cultivation in guinea pig heart cells","volume":"73","author":"Berge","year":"1961","journal-title":"Am J Hyg"},{"key":"10.1016\/j.vaccine.2004.06.056_bib6","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/0264-410X(95)00168-Z","article-title":"Long-term duration of detectable neutralizing antibodies after administration of live-attenuated VEE vaccine and following booster vaccination with inactivated VEE vaccine","volume":"14","author":"Pittman","year":"1996","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2004.06.056_bib7","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/S0264-410X(97)00192-8","article-title":"Use of telemetry to assess vaccine-induced protection against parenteral and aerosol infections of Venezuelan equine encephalitis virus in non-human primates","volume":"16","author":"Pratt","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2004.06.056_bib8","doi-asserted-by":"crossref","first-page":"762","DOI":"10.4269\/ajtmh.1967.16.762","article-title":"Live, attenuated Venezuelan equine encephalomyelitis vaccine","volume":"16","author":"Alevizatos","year":"1967","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2004.06.056_bib9","first-page":"13","article-title":"Necrosis cerebra massiva del feto en casos de encefalitis equina Venezolana","volume":"21","author":"Wenger","year":"1967","journal-title":"Invest Clin"},{"key":"10.1016\/j.vaccine.2004.06.056_bib10","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/tera.1420360303","article-title":"TC83 Venezuelan encephalitis exposure during pregnancy","volume":"36","author":"Casamassima","year":"1987","journal-title":"Teratology"},{"key":"10.1016\/j.vaccine.2004.06.056_bib11","first-page":"81","article-title":"Effecto teratogenico del virus de la encefalitis equina Venezolana, una revision del problema","volume":"33","author":"Garcia-Tamayo","year":"1992","journal-title":"Invest Clin"},{"key":"10.1016\/j.vaccine.2004.06.056_bib12","first-page":"621","article-title":"Virus-induced pancreatid disease induced by Venezuelan equine encephalitis virus. Alterations in glucose tolerance and insulin release","volume":"25","author":"Rayfield","year":"1976","journal-title":"J Am Diab Assoc"},{"key":"10.1016\/j.vaccine.2004.06.056_bib13","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1177\/030098589803500508","article-title":"Comparative neurovirulence and tissue tropism of wild-type and attenuated strains of Venezuelan equine encephalitis virus administered by aerosol in C3H\/HeN and BALB\/c mice","volume":"35","author":"Steele","year":"1998","journal-title":"Vet Pathol"},{"key":"10.1016\/j.vaccine.2004.06.056_bib14","doi-asserted-by":"crossref","first-page":"3854","DOI":"10.1016\/S0264-410X(03)00328-1","article-title":"Genetically engineered, live attenuated vaccines for Venezuelan equine encephalitis: testing in animal models","volume":"21","author":"Pratt","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2004.06.056_bib15","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1128\/AEM.27.1.150-153.1974","article-title":"Inactivated with Venezuelan equine encephalomyelitis vaccine prepared from attenuated (TC-83 strain) virus","volume":"27","author":"Cole","year":"1974","journal-title":"Appl Microbiol"},{"key":"10.1016\/j.vaccine.2004.06.056_bib16","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/0264-410X(95)00076-D","article-title":"Enhancement of protective immune responses to Venezuelan equine encephalitis (VEE) virus with microencapsulated vaccine","volume":"13","author":"Greenway","year":"1995","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2004.06.056_bib17","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/S0264-410X(98)00008-5","article-title":"Induction of protective immune responses against Venezuelan equine encephalitis (VEE) virus aerosol challenge with microencapsulated VEE virus vaccine","volume":"16","author":"Greenway","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2004.06.056_bib18","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/S0264-410X(98)00335-1","article-title":"Expression, processing and immunogenicity of the structural proteins of Venezuelan equine encephalitis virus from recombinant baculovirus vectors","volume":"17","author":"Hodgson","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2004.06.056_bib19","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1099\/0022-1317-69-12-3005","article-title":"Recombinant vaccinia\/Venezuelan equine encephalitis (VEE) virus expresses VEE structural proteins","volume":"69","author":"Kinney","year":"1988","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2004.06.056_bib20","first-page":"222","article-title":"Immunogenic properties of a recombinant vaccinia virus with incorporated cDNA copy of 26S RNA of Venezuelan equine encephalomyelitis virus","volume":"38","author":"Svyatchenko","year":"1993","journal-title":"Voprosy Virusologii"},{"key":"10.1016\/j.vaccine.2004.06.056_bib21","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1089\/vim.1998.11.109","article-title":"Improved protection against Venezuelan equine encephalitis by genetic engineering of a recombinant vaccinia virus","volume":"11","author":"Bennett","year":"1998","journal-title":"Viral Immunol"},{"key":"10.1016\/j.vaccine.2004.06.056_bib22","first-page":"233","article-title":"Vaccinia virus recombinants encoding the truncated structural gene region of Venezuelan equine encephalitis virus (VEEV) give solid protection against peripheral challenge but only partial protection against airborne challenge with virulent VEEV","volume":"44","author":"Phillpotts","year":"2000","journal-title":"Acta Virol"},{"key":"10.1016\/j.vaccine.2004.06.056_bib23","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1099\/0022-1317-81-11-2573","article-title":"Update on adenovirus and its vectors","volume":"81","author":"Russell","year":"2000","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2004.06.056_bib24","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1093\/infdis\/168.3.622","article-title":"Mucosal immunity and protection after intranasal immunisation with recombinant adenovirus expressing herpes simplex virus glycoprotein B","volume":"168","author":"Gallichan","year":"1993","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2004.06.056_bib25","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1128\/JCM.19.3.429-431.1984","article-title":"Protective efficacies of live-attenuated and formaldehyde-inactivated Venezuelan equine encephalitis virus vaccines against aerosol challenge in hamsters","volume":"19","author":"Jahrling","year":"1984","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2004.06.056_bib26","first-page":"71","article-title":"Venezuelan equine encephalitis virus vaccines induce mucosal IgA responses and protection from airborne infection in Balb\/c but not C3H\/HeN mice","volume":"118","author":"Hart","year":"1997","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2004.06.056_bib27","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/S0264-410X(98)00315-6","article-title":"TC-83 vaccine protects against disease produced by airborne or subcutaneous infection with heterologous mouse-virulent strains of Venezuelan equine encephalitis virus","volume":"17","author":"Phillpotts","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2004.06.056_bib28","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1128\/MMBR.58.3.491-562.1994","article-title":"The alphaviruses: gene expression, replication and evolution","volume":"58","author":"Straus","year":"1994","journal-title":"Microbiol Rev"},{"key":"10.1016\/j.vaccine.2004.06.056_bib29","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.4049\/jimmunol.129.6.2763","article-title":"Determination of the protective epitopes on the glycoproteins of Venezuelan equine encephalomyelitis virus by passive transfer of monoclonal antibodies","volume":"129","author":"Mathews","year":"1982","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2004.06.056_bib30","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1128\/JVI.55.3.594-600.1985","article-title":"Role of complement and the Fc portion of immunoglobulin G in immunity Venezuelan equine encephalomyelitis virus infection with glycoprotein-specific monoclonal antibodies","volume":"54","author":"Mathews","year":"1985","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2004.06.056_bib31","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/S0264-410X(01)00505-9","article-title":"Monoclonal antibody protects mice against infection and disease when given either before or up to 24h after airborne challenge with virulent Venezuelan equine encephalitis virus","volume":"20","author":"Phillpotts","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2004.06.056_bib32","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/0092-8674(79)90275-7","article-title":"Isolation of adenovirus type 5 host range deletion mutants defective for transformation of rat embryo cells","volume":"17","author":"Jones","year":"1979","journal-title":"Cell"},{"key":"10.1016\/j.vaccine.2004.06.056_bib33","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/0168-1702(95)00071-W","article-title":"DNA sequence of the deletion\/insertion in early region 3 of Ad5 dl309","volume":"39","author":"Bett","year":"1995","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2004.06.056_bib34","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/0042-6822(88)90302-9","article-title":"A simple technique for the rescue of early region I mutations into infectious human adenovirus type 5","volume":"163","author":"McGrory","year":"1988","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2004.06.056_bib35","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/0042-6822(89)90279-1","article-title":"Cloning of the herpes simplex virus ICP4 gene in an adenovirus vector: effects on adenovirus gene expression and replication","volume":"168","author":"Spessot","year":"1989","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2004.06.056_bib36","series-title":"Adenovirus methods and protocols","first-page":"1","article-title":"Preparation and titration of CsCl-banded adenovirus stock","author":"Tollefson","year":"1999"},{"key":"10.1016\/j.vaccine.2004.06.056_bib37","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/0042-6822(85)90343-5","article-title":"The neutralization site on the E2 glycoprotein of Venezuelan equine encephalomyelitis (TC-83) virus is composed of multiple conformationally stable epitopes","volume":"142","author":"Roehrig","year":"1985","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2004.06.056_bib38","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1080\/15321818108056977","article-title":"3,3\u2032,5,5\u2032-Tetramethylbenzidine as an Ames test negative chromogen for horseradish peroxidase in enzyme-immunoassay","volume":"2","author":"Bos","year":"1981","journal-title":"J Immunoassay"},{"key":"10.1016\/j.vaccine.2004.06.056_bib39","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1017\/S0950268896007157","article-title":"A simple device for exposure of animals to infectious microorganisms by the airborne route","volume":"118","author":"Phillpotts","year":"1997","journal-title":"J Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2004.06.056_bib40","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1152\/ajplegacy.1947.150.1.70","article-title":"Measurement of the respiratory volume of laboratory animals","volume":"150","author":"Guyton","year":"1947","journal-title":"Am J Physiol"},{"key":"10.1016\/j.vaccine.2004.06.056_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s007050050363","article-title":"Humane endpoints are an objective measure of morbidity in Venezuelan encephalomyelitis virus infection of mice","volume":"143","author":"Wright","year":"1998","journal-title":"Arch Virol"},{"key":"10.1016\/j.vaccine.2004.06.056_bib42","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0042-6822(89)90347-4","article-title":"The full length sequences of the virulent Trinidad donkey strain of Venezuelan equine encephalitis virus and its attenuated vaccine derivative, strain TC-83","volume":"170","author":"Kinney","year":"1989","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2004.06.056_bib43","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/0042-6822(90)90137-G","article-title":"Synthetic peptides of Venezuelan equine encephalomyelitis virus E2 glycoprotein I: Immunogenic analysis and identification of a protective peptide","volume":"179","author":"Hunt","year":"1990","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2004.06.056_bib44","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/0042-6822(88)90659-9","article-title":"In vitro mechanisms of monoclonal antibody neutralisation of alphaviruses","volume":"165","author":"Roehrig","year":"1988","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2004.06.056_bib45","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/35046108","article-title":"Development of a preventative vaccine for Ebola virus infection in primates","volume":"408","author":"Sullivan","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2004.06.056_bib46","doi-asserted-by":"crossref","first-page":"952","DOI":"10.4269\/ajtmh.1998.59.952","article-title":"Nucleotides sequences of the 26S mRNAs of the viruses defining the Venezuelan equine encephalitis antigenic complex","volume":"59","author":"Kinney","year":"1998","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2004.06.056_bib47","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1093\/infdis\/124.2.155","article-title":"Immunisation with live types 7 and 4 adenovirus vaccines. II. Antibody response and protective effect against acute respiratory disease due to adenovirus type 7","volume":"124","author":"Top","year":"1971","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2004.06.056_bib48","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1006\/viro.2002.1771","article-title":"Individual expression of sindbis virus glycoproteins. E1 alone promotes cell fusion","volume":"305","author":"Sanz","year":"2003","journal-title":"Virology"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X04007182?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X04007182?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,30]],"date-time":"2023-04-30T02:03:24Z","timestamp":1682820204000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X04007182"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,2]]},"references-count":48,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2005,2]]}},"alternative-id":["S0264410X04007182"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2004.06.056","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2005,2]]}}}